Peroxidase polymer reagents, 2/13:113
Vector Laboratories has added to its line of Western blot detection reagents two highly active WestVision peroxidase polymer antibody conjugates.
Webinars and Sponsored Roundtables — Register Now
Thursday, May 28, 2026, 1:00–2:00 PM ET
This session is designed to improve understanding and application of recent updates to synoptic pathology reporting protocols such as the latest Reporting Template for Reporting Results of Biomarker Testing of Specimens from Patients with Carcinoma of the Breast. These changes reflect evolving clinical guidelines that directly influence diagnostic accuracy and treatment selection in breast cancer care.
Webinar presenters Thaer Khoury, MD, FCAP, Chair, Pathology and Laboratory Medicine, Roswell Park Comprehensive Cancer Cente, and Colin Murphy, CEO of mTuitive.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Tuesday, June 9, 2026, 1:00–2:00 PM ET
In this webinar, we will examine how immune recognition after allogeneic HCT can influence leukemia relapse and disease progression. The session will highlight the clinical relevance of HLA loss of heterozygosity (LOH), approaches used for its detection, and how LOH findings may support transplant strategies, including considerations for donor selection in subsequent transplantation.
Webinar presenter Alberto Cardoso Martins Lima, PhD, Clinical consulting scientist in histocompatibility,
specializing in allogeneic hematopoietic cell transplantation (HCT) at IGEN/AFIP São Paulo and CHC/UFPR in Curitiba, Brazil
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Wednesday, June 24, 2026, 12:00–1:00 PM ET
Hear an expert discuss the expanded clinical utility of HER2 IHC scoring in metastatic breast cancer and its impact on your practice
Webinar presenter Michelle Shiller, DO, AP, CP, MGP, FACP, Baylor University Medical Center.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Subspecialties
Interactive Product Guides
Marketplace Directory
Bio-Rad to acquire MorphoSys’ AbD Serotec, 2/13:113
MorphoSys in December signed a definitive agreement to sell its AbD Serotec research and diagnostic antibody segment to Bio-Rad Laboratories.
Vitamin D test, 2/13:113
Diazyme Laboratories has received FDA 510(k) clearance to market its new 25-hydoxy vitamin D assay, which measures total true 25-hydroxy vitamin D levels in serum and plasma samples. The assay automates the removal of nonspecific protein binding and cross-reactivity that may occur in competing assays, thereby ensuring results will be precise and accurate.
Hemophilia genetics testing, 2/13:113
BloodCenter of Wisconsin’s Diagnostic Laboratories has expanded its genetic testing menu for hemophilia. Its new approach to hemophilia genetics allows BloodCenter to identify the genetic abnormality in greater than 95 percent of all hemophilia patients.
Human monoclonal antibodies for flow cytometry, 2/13:113
Beckman Coulter Life Sciences has added to its flow cytometry portfolio 14 new human monoclonal antibodies from Trillium Diagnostics. The analyte-specific reagents are highly specific, convenient, and flexible. Also offered is a new cell permeabilization reagent.
Trichomonas test, 2/13:113
Hologic has received FDA clearance to market its Aptima Trichomonas vaginalis assay on the company’s automated Panther system.
T. gondii products, 2/13:113
Meridian Life Science offers several new Toxoplasma gondii products.
Chembio: Positive data from syphilis test study, 2/13:112
Chembio Diagnostics reported that data from a study evaluating the sensitivity and specificity of the company’s point-of-care Dual Path Platform (DPP) rapid test for syphilis was recently published online in Clinical Infectious Diseases.
MDxHealth, Ghent form pharmacoepigenomics center, 2/13:112
MDxHealth has joined forces with Ghent University to establish NXTGNT, a pharmacoepigenomics center.
High-volume coagulation analyzer, 2/13:112
Siemens Healthcare Diagnostics Sysmex CS-5100 system, a random-access high-volume coagulation analyzer, is now available in Europe, Africa, Canada, Latin America, Australia, and New Zealand. It is equipped with multi-wavelength preanalytical sample integrity technology, enabling high-volume laboratories to achieve first-run accuracy by identifying and managing unsuitable test specimens before analysis.